Redox Regulation of the Human Xenobiotic Metabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1)

Oxidative stress is increasingly recognized as a key mechanism in the biotransformation and/or toxicity of many xenobiotics. Human arylamine N-acetyltransferase 1 (NAT1) is a polymorphic ubiquitous phase II xenobiotic metabolizing enzyme that catalyzes the biotransformation of primary aromatic amine or hydrazine drugs and carcinogens. Functional and structural studies have shown that NAT1 catalytic activity is based on a cysteine protease-like catalytic triad, containing a reactive cysteine residue. Reactive protein cysteine residues are highly susceptible to oxidation by hydrogen peroxide (H2O2) generated within the cell. We, therefore, investigated whether human NAT1 activity was regulated by this cellular oxidant. Using purified recombinant NAT1, we show here that NAT1 is rapidly (kinact = 420 m–1·min–1) inactivated by physiological concentrations of H2O2. Reducing agents, such as reduced glutathione (GSH), reverse the H2O2-dependent inactivation of NAT1. Kinetic analysis and protection experiments with acetyl-CoA, the physiological acetyl-donor substrate of the enzyme, suggested that the H2O2-dependent inactivation reaction targets the active-site cysteine residue. Finally, we show that the reversible inactivation of NAT1 by H2O2 is due to the formation of a stable sulfenic acid group at the active-site cysteine. Our results suggest that, in addition to known genetically controlled interindividual variations in NAT1 activity, oxidative stress and cellular redox status may also regulate NAT1 activity. This may have important consequences with regard to drug biotransformation and cancer risk.

[1]  L. Lian,et al.  NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium. , 2003, Biochimica et biophysica acta.

[2]  C. Jacob,et al.  Multiple roles of cysteine in biocatalysis. , 2003, Biochemical and biophysical research communications.

[3]  L. Netto,et al.  20 S Proteasome from Saccharomyces cerevisiae Is Responsive to Redox Modifications and IsS-Glutathionylated* , 2003, The Journal of Biological Chemistry.

[4]  Michael Reth,et al.  Hydrogen peroxide as second messenger in lymphocyte activation , 2002, Nature Immunology.

[5]  G. Georgiou.  How to Flip the (Redox) Switch , 2002, Cell.

[6]  U. Boelsterli,et al.  Mechanistic toxicology : the molecular basis of how chemicals disrupt biological targets , 2002 .

[7]  D. Galaris,et al.  DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2 , 2002 .

[8]  G. Filomeni,et al.  Cell signalling and the glutathione redox system. , 2002, Biochemical pharmacology.

[9]  K. Carraway,et al.  Epidermal Growth Factor Receptor Activation under Oxidative Stress Fails to Promote c-Cbl Mediated Down-regulation* , 2002, The Journal of Biological Chemistry.

[10]  P. Stemmer,et al.  Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. , 2002, Archives of biochemistry and biophysics.

[11]  B. Blömeke,et al.  NAT— from bugs to brains An overview of the 2nd International Workshop on the arylamine N-acetyltransferases , 2002, The Pharmacogenomics Journal.

[12]  T. Finkel,et al.  Redox Regulation of Cdc25C* , 2002, The Journal of Biological Chemistry.

[13]  Woojin Jeong,et al.  Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.

[14]  M. Noble,et al.  The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid. , 2002, Journal of molecular biology.

[15]  J. Dupret,et al.  In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria. , 2002, Biochemical and biophysical research communications.

[16]  P. Meisel.  Arylamine N-acetyltransferases and drug response. , 2002, Pharmacogenomics.

[17]  I. Stamenkovic,et al.  Interaction with substrate sensitises caspase‐3 to inactivation by hydrogen peroxide , 2002, FEBS letters.

[18]  E. Sim,et al.  The COOH Terminus of Arylamine N-Acetyltransferase from Salmonella typhimurium Controls Enzymic Activity* , 2002, The Journal of Biological Chemistry.

[19]  J. Dupret,et al.  3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop. , 2002, Biochemical and biophysical research communications.

[20]  G. Pagano.  Redox-modulated xenobiotic action and ROS formation: a mirror or a window? , 2002, Human & experimental toxicology.

[21]  L. Feinendegen,et al.  Reactive oxygen species in cell responses to toxic agents , 2002, Human & experimental toxicology.

[22]  C. Cross,et al.  Inactivation of glutathione S-transferases by nitric oxide-derived oxidants: exploring a role for tyrosine nitration. , 2001, Archives of biochemistry and biophysics.

[23]  M. Doll,et al.  Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1. , 2001, Pharmacogenetics.

[24]  V. Borutaite,et al.  Caspases are reversibly inactivated by hydrogen peroxide , 2001, FEBS letters.

[25]  M. Hentze,et al.  IRP1 Activation by Extracellular Oxidative Stress in the Perfused Rat Liver* , 2001, The Journal of Biological Chemistry.

[26]  D. Grant,et al.  Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. , 2001, The Biochemical journal.

[27]  E. Sim,et al.  Arylamine N-acetyltransferases - of mice, men and microorganisms. , 2001, Trends in pharmacological sciences.

[28]  R. Minchin,et al.  Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid. , 2000, Biochemical pharmacology.

[29]  B. Halliwell,et al.  Hydrogen peroxide in the human body , 2000, FEBS letters.

[30]  M. Katan,et al.  Structural requirements for catalysis and membrane targeting of mammalian enzymes with neutral sphingomyelinase and lysophospholipid phospholipase C activities. Analysis by chemical modification and site-directed mutagenesis. , 2000, The Journal of biological chemistry.

[31]  M. Noble,et al.  Structure of arylamine N-acetyltransferase reveals a catalytic triad , 2000, Nature Structural Biology.

[32]  D. Grant,et al.  Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. , 2000, The Biochemical journal.

[33]  W. MacNee,et al.  Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. , 2000, Free radical biology & medicine.

[34]  R. Minchin,et al.  Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. , 2000, Molecular pharmacology.

[35]  E. Shacter.  QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES* , 2000, Drug metabolism reviews.

[36]  Joanne I. Yeh,et al.  Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. , 1999, Biochemistry.

[37]  Christine Campagnolo,et al.  Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. , 1999, Biochemistry.

[38]  R. Barouki,et al.  Repression of gene expression by oxidative stress. , 1999, The Biochemical journal.

[39]  M. Panayiotidis,et al.  Glucose oxidase-produced H2O2 induces Ca2+-dependent DNA damage in human peripheral blood lymphocytes. , 1999, Free radical biology & medicine.

[40]  G. Ramponi,et al.  The Inactivation Mechanism of Low Molecular Weight Phosphotyrosine-protein Phosphatase by H2O2 * , 1998, The Journal of Biological Chemistry.

[41]  S. Rhee,et al.  Probing cellular protein targets of H2O2 with fluorescein‐conjugated iodoacetamide and antibodies to fluorescein , 1998, FEBS letters.

[42]  H. Le.  The promise of molecular biomarkers for environmental monitoring. , 1998 .

[43]  S. Rhee,et al.  Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[44]  J. Denu,et al.  Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. , 1998, Biochemistry.

[45]  L. Poole,et al.  Novel application of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole to identify cysteine sulfenic acid in the AhpC component of alkyl hydroperoxide reductase. , 1997, Biochemistry.

[46]  A. Risch,et al.  Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. , 1997, Cytogenetics and cell genetics.

[47]  A. Cederbaum,et al.  Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. , 1997, Archives of biochemistry and biophysics.

[48]  E. Sim,et al.  A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis. , 1997, Biochemical pharmacology.

[49]  Kuo-ping Huang,et al.  Nitric Oxide Modification of Rat Brain Neurogranin , 1996, The Journal of Biological Chemistry.

[50]  T. Penning,et al.  Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. , 1996, Chemical research in toxicology.

[51]  A. Hausladen,et al.  Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. , 1994, The Journal of biological chemistry.

[52]  D. Grant,et al.  Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2. , 1992, The Journal of biological chemistry.

[53]  D. Grant,et al.  Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. , 1991, Molecular pharmacology.

[54]  D. Grant,et al.  Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. , 1990, DNA and cell biology.

[55]  L. Schopfer,et al.  On the active site of liver acetyl-CoA. Arylamine N-acetyltransferase from rapid acetylator rabbits (III/J). , 1988, The Journal of biological chemistry.

[56]  F. Pompeo,et al.  The pharmacogenetics of NAT: structural aspects. , 2002, Pharmacogenomics.

[57]  R. Minchin,et al.  Pharmacogenetics of the arylamine N-acetyltransferases , 2002, The Pharmacogenomics Journal.

[58]  Joanne I. Yeh,et al.  Structural, redox, and mechanistic parameters for cysteine-sulfenic acid function in catalysis and regulation. , 2001, Advances in protein chemistry.

[59]  V. Culotta,et al.  Superoxide dismutase, oxidative stress, and cell metabolism. , 2000, Current topics in cellular regulation.

[60]  Identification and Functional Characterization of Arylamine N -Acetyltransferases in Eubacteria: Evidence for Highly Selective Acetylation of 5-Aminosalicylic Acid , 2022 .